ACADIA Pharmaceuticals Inc (ACAD)

NASDAQ
21.83
+0.99(+4.75%)
After Hours
21.85
+0.02(+0.09%)
- Real-time Data
  • Volume:
    2,300,170
  • Bid/Ask:
    21.90/21.98
  • Day's Range:
    20.74 - 22.33

ACAD Overview

Prev. Close
20.84
Day's Range
20.74 - 22.33
Revenue
458.24M
Open
20.77
52 wk Range
19.2 - 58.72
EPS
-1.64
Volume
2,300,170
Market Cap
3.34B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
2,695,244
P/E Ratio
-
Beta
0.74
1-Year Change
-55.78%
Shares Outstanding
160,179,036
Next Earnings Date
Aug 11, 2021
What is your sentiment on ACADIA Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

ACADIA Pharmaceuticals Inc News

ACADIA Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyNeutralStrong Sell
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Sell
SummaryStrong SellSellStrong BuyBuyStrong Sell

ACADIA Pharmaceuticals Inc Company Profile

ACADIA Pharmaceuticals Inc Company Profile

Employees
601

ACADIA Pharmaceuticals Inc. (ACADIA) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines to address the medical needs in central nervous system disorders. The Company's lead product, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA’s developments are focused on pimavanserin for additional neuropsychiatric conditions, trofinetide for Rett syndrome, ACP-044 for pain management and an early-stage muscarinic receptor program.

Read More
  • 4197 close imo
    0
    • A italian journalist predict a new clinical trail for the sustrate. This will take time i suppose.
      0
      • Somebody knows something.
        0
        • https://www.trefis.com/stock/acad/articles/510930/acadia-pharmaceuticals-stock-now-looks-oversold-at-27-levels/2021-03-15
          0
          • Lowest downgrade is 27usd do...it can,t be that wrong.
            0
            • Paperhands are out.
              0
              • 30 next week
                0
                • 26
                  0
                  • Ok, some aftermarket
                    0
                    • I am guessing this will fly in the aftermarket.
                      0
                      • Why this stock is so down?
                        0
                        • Today its go more dwon
                          0
                          • Who knows it's green now but
                            0
                        • So I don't follow highly paid analysts' recommendations, they have their own business in it.
                          0
                          • Is it good to buy at 25$?
                            0
                          • Jobir Avezov  Yes, but don't be hurry, the time will come.
                            0
                          • Thank you
                            0
                        • Seems to have stalled. Is something happening
                          0
                          • here it'll be good
                            0
                            • Buy, 2021 will be great
                              1
                              • ACAD is a buy, we should see 5% higher next week.
                                0
                                • falling
                                  0
                                  • Let's see where it's go from here
                                    0
                                    • What do you think the maximum will be by the end of April?
                                      0
                                      • Great to buy now, holding
                                        1
                                        • Why doesn’t the management come out and clarify?
                                          0
                                          • If ACAD breaks $33.45 resistance, it reaches $48 by end of March.
                                            0
                                            • this aged poorly
                                              0
                                            • this aged poorly
                                              0
                                          • 29$, is buy or sell ?
                                            0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.